doi: 10.1007/BF01973267.
Inactivation of bradykinin the plumonary circulation
- PMID: 961547
- DOI: 10.1007/BF01973267
Item in Clipboard
Inactivation of bradykinin the plumonary circulation
Agents Actions.
1976 Jul.
Abstract
Bradykinin is very efficiently inactivated on passage through the pulmonary circulation by enzymes on the vascular walls. Several different cleavages of the bradykinin molecule have been observed; one appears to be due to angiotensin converting enzyme. Several types of inhibitors have been useful in the study of these pulmonary peptidases and have helped increase understanding of the functioning of the angiotensin and plasma kinin systems.
Similar articles
-
Pulmonary kinin metabolism and conversion of angiotensin I in spontaneously hypertensive rats.J Hypertens. 1992 Dec;10(12):1479-84. doi: 10.1097/00004872-199210120-00007. J Hypertens. 1992. PMID: 1363433
-
In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat.Arch Int Pharmacodyn Ther. 1975 Sep;217(1):97-109. Arch Int Pharmacodyn Ther. 1975. PMID: 172037
-
Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.Br J Pharmacol. 1977 Jan;59(1):123-8. doi: 10.1111/j.1476-5381.1977.tb06985.x. Br J Pharmacol. 1977. PMID: 189870 Free PMC article.
-
Pharmacokinetic function of the pulmonary circulation.Physiol Rev. 1974 Oct;54(4):1007-45. doi: 10.1152/physrev.1974.54.4.1007. Physiol Rev. 1974. PMID: 4371230 Review. No abstract available.
-
Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology.J Cardiovasc Pharmacol. 1992;20 Suppl 9:S4-9. doi: 10.1097/00005344-199200209-00003. J Cardiovasc Pharmacol. 1992. PMID: 1282629 Review.